- A. Health Biotechnology
- Areas of activity
- Medical devices
- Therapeutic areas
- Cardiovascular diseases and circulatory system
- C. Industrial Biotechnology
- Manufacture of biotech equipment
CORIFY Care SL (Corify) is a medical start-up focused on cardiac arrhythmias. We are developing a novel technology to improve the treatment of atrial fibrillation.
About 6 M people in Europe suffer from Atrial Fibrillation (AF), the most common cardiac arrhythmia. By 2050, 2% of the world population will be affected by this condition. The highly effective treatment is ablation. However, a precise diagnosis comes first. This is where the challenge lies. Only with a detailed diagnosis can we stratify AF patients precisely and give them the best treatment.
Our vision is to optimise existing medical procedures in the field of cardiology. The medical sector is in need of faster, easier-to-use solutions, especially for common pathologies. CORIFY is a first and representative example: a medical device that makes ablation more efficient and more accessible to patients.
Artificial intelligence, development and distribution of medical devices, data management and processing systems